SG11201704737SA - Novel aqueous composition - Google Patents

Novel aqueous composition

Info

Publication number
SG11201704737SA
SG11201704737SA SG11201704737SA SG11201704737SA SG11201704737SA SG 11201704737S A SG11201704737S A SG 11201704737SA SG 11201704737S A SG11201704737S A SG 11201704737SA SG 11201704737S A SG11201704737S A SG 11201704737SA SG 11201704737S A SG11201704737S A SG 11201704737SA
Authority
SG
Singapore
Prior art keywords
aqueous composition
novel aqueous
novel
composition
aqueous
Prior art date
Application number
SG11201704737SA
Other languages
English (en)
Inventor
Isamu Sawai
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of SG11201704737SA publication Critical patent/SG11201704737SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG11201704737SA 2014-12-12 2015-12-11 Novel aqueous composition SG11201704737SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014251708 2014-12-12
PCT/JP2015/084802 WO2016093344A1 (ja) 2014-12-12 2015-12-11 新規水性組成物

Publications (1)

Publication Number Publication Date
SG11201704737SA true SG11201704737SA (en) 2017-07-28

Family

ID=56107521

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704737SA SG11201704737SA (en) 2014-12-12 2015-12-11 Novel aqueous composition

Country Status (11)

Country Link
US (1) US10220043B2 (pt)
EP (1) EP3231429B1 (pt)
JP (2) JP5951920B1 (pt)
KR (1) KR102502053B1 (pt)
CN (1) CN107106571B (pt)
BR (1) BR112017012487A2 (pt)
CA (1) CA2970263A1 (pt)
MX (1) MX2017007573A (pt)
MY (1) MY178881A (pt)
SG (1) SG11201704737SA (pt)
WO (1) WO2016093344A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI671071B (zh) * 2014-09-25 2019-09-11 日商興和股份有限公司 醫藥製劑
TWI699205B (zh) * 2014-12-12 2020-07-21 日商興和股份有限公司 用於預防或治療青光眼之藥物療法
CA3086445A1 (en) * 2017-12-21 2019-06-27 Santen Pharmaceutical Co., Ltd. Omidenepag combination
WO2019235456A1 (ja) * 2018-06-05 2019-12-12 千寿製薬株式会社 水性液剤
JP2020033290A (ja) * 2018-08-29 2020-03-05 興和株式会社 水性組成物
CN109734701B (zh) * 2019-03-04 2020-07-14 中国药科大学 Rock抑制剂-二氯乙酸复盐及其制备方法和用途
CN111518028B (zh) * 2020-05-12 2024-06-25 中国药科大学 一种一氧化氮供体型ripasudil衍生物及其制备方法和用途
CN116159018A (zh) * 2023-03-01 2023-05-26 中国药科大学 一种新型外用溴莫尼定凝胶剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4212149B2 (ja) 1998-06-11 2009-01-21 株式会社デ・ウエスタン・セラピテクス研究所 医薬
US7718797B2 (en) 2004-03-16 2010-05-18 Asahi Kasei Pharma Corporation Fasudil-containing preparation and method of improving stability thereof
US20060142270A1 (en) * 2004-12-23 2006-06-29 Kowa Co., Ltd. Preventing or treating agent for glaucoma
TWI367098B (en) 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
WO2006115244A1 (ja) 2005-04-25 2006-11-02 D. Western Therapeutics Institute, Inc. 4-ブロモイソキノリン誘導体及びこれを含有する医薬
CN101198354B (zh) * 2005-06-21 2012-01-11 兴和株式会社 青光眼的预防或治疗剂
JP4800720B2 (ja) 2005-09-21 2011-10-26 興和株式会社 点眼用組成物
JP2012250953A (ja) * 2011-06-06 2012-12-20 Santen Pharmaceut Co Ltd アデノシン誘導体とα2受容体作動薬の組合せ剤
JP2013035802A (ja) * 2011-08-10 2013-02-21 D Western Therapeutics Institute Inc 緑内障又は高眼圧症の予防又は治療剤
TWI699205B (zh) 2014-12-12 2020-07-21 日商興和股份有限公司 用於預防或治療青光眼之藥物療法

Also Published As

Publication number Publication date
JP2016155870A (ja) 2016-09-01
CA2970263A1 (en) 2016-06-16
EP3231429B1 (en) 2021-03-17
EP3231429A1 (en) 2017-10-18
WO2016093344A1 (ja) 2016-06-16
MX2017007573A (es) 2018-01-17
KR20170095847A (ko) 2017-08-23
KR102502053B1 (ko) 2023-02-20
CN107106571A (zh) 2017-08-29
BR112017012487A2 (pt) 2017-12-26
US10220043B2 (en) 2019-03-05
JPWO2016093344A1 (ja) 2017-04-27
JP5951920B1 (ja) 2016-07-13
EP3231429A4 (en) 2018-08-08
CN107106571B (zh) 2021-02-05
US20170360799A1 (en) 2017-12-21
MY178881A (en) 2020-10-21

Similar Documents

Publication Publication Date Title
SG11201704737SA (en) Novel aqueous composition
HK1218859A1 (zh) 組合物
HK1214967A1 (zh) 組合物
SG11201704735WA (en) Composition
SG11201704740WA (en) Aqueous composition
LT3216451T (lt) Oftalmologinė vandeninė kompozicija
GB201403017D0 (en) Composition
HK1244432A1 (zh) 組合物
GB201414910D0 (en) Composition
ZA201704464B (en) Composition
GB201403561D0 (en) Composition
GB201414555D0 (en) Composition
GB201410493D0 (en) Composition
SG11201702202UA (en) Aqueous composition
GB201519442D0 (en) Composition
ZA201606127B (en) Composition
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404700D0 (en) Novel Composition
GB201404390D0 (en) Composition
GB201402648D0 (en) Composition
IL250781A0 (en) preparation
GB201503484D0 (en) Composition
GB201502355D0 (en) Composition
GB201421660D0 (en) Composition